triazoles has been researched along with Heart Disease, Ischemic in 23 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 9 (39.13) | 18.2507 |
| 2000's | 5 (21.74) | 29.6817 |
| 2010's | 9 (39.13) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Buendia, I; Casas, AI; Egea, J; Geuss, E; Herrmann, AM; Kleikers, PWM; Kleinschnitz, C; Lopez, MG; Mencl, S; Meuth, SG; Schmidt, HHHW | 1 |
| Asche, CV; Eurich, DT; McAlister, FA; Sandhu-Minhas, JK; Senthilselvan, A; Simpson, S | 1 |
| Franz, WM; Hiergeist, L; Kozlik-Feldmann, R; Mechea, A; Netz, H; Theisen, D; Zaruba, MM | 1 |
| Bessi, VL; Bitencourt, CS; Borgeat, P; Faccioli, LH; Hamdan, L; Huynh, DN; Lefebvre, JS; Lévesque, T; Marleau, S; Ménard, L; Sohouhenou, F | 1 |
| Bond, SJ; Dutka, DP; Hoole, SP; Kydd, AC; McCormick, LM; Read, PA; Ring, LS | 1 |
| Bourassa, L; O'Brien, KD; Rakita, RM | 1 |
| Church, JE; Coupar, IM; Pouton, CW; Rose'Meyer, RB; Urmaliya, VB; White, PJ | 1 |
| Ban, K; Drucker, DJ; Henkelman, RM; Husain, M; Momen, MA; Sauvé, M; Zhou, YQ | 1 |
| Berwick, ZC; Dick, GM; Lynch, B; Payne, GA; Sturek, M; Tune, JD | 1 |
| Belardinelli, L; Crumb, W; Dhalla, AK; El-Bizri, N; Hirakawa, R; Hu, L; Karpinski, S; Koltun, D; Li, CH; Li, XJ; Liu, G; Rajamani, S; Shryock, JC; Smith-Maxwell, C; Wang, WQ; Wu, L; Yao, L; Zablocki, J | 1 |
| Csiba, L; Ficzere, A | 1 |
| Baker, KE; Curtis, MJ | 2 |
| Birnbaum, DE; Jagiello, M; Liebold, A; Retzl, G; Wieland, T | 1 |
| Keith, BJ; Kristo, G; Lasley, RD; Mentzer, RM | 1 |
| Becker, BF; Raschke, P | 1 |
| Alloatti, G; Cacace, G; Camussi, G; Comino, A; De Filippi, PG; Emanuelli, G; Mariano, F; Montrucchio, G; Polloni, R | 1 |
| Hackett, D; O'Gorman, DJ; Shahi, M; Sheridan, DJ; Siminiak, T | 1 |
| Dézsi, L; Metsä-Ketelä, T; Monos, E; Szekeres, M | 1 |
| Hata, K; Kloner, RA; Przyklenk, K; Whittaker, P | 1 |
| Porsius, AJ; Vleeming, W; Wemer, J | 1 |
| Black, SC; Driscoll, EM; Lucchesi, BR | 1 |
| Chakrabarty, S; Flores, NA; Fluck, DS; Sheridan, DJ | 1 |
1 review(s) available for triazoles and Heart Disease, Ischemic
| Article | Year |
|---|---|
[Treatment of migraine in patients with hypertension and ischemic heart disease].
Topics: Adjuvants, Pharmaceutic; Analgesics, Non-Narcotic; Anti-Inflammatory Agents, Non-Steroidal; Carbazoles; Contraindications; Dihydroergotamine; Dopamine Agonists; Ergotamine; Humans; Hypertension; Indoles; Migraine Disorders; Myocardial Ischemia; Oxazolidinones; Retrospective Studies; Serotonin Receptor Agonists; Sumatriptan; Triazoles; Tryptamines; Vasoconstrictor Agents | 2002 |
1 trial(s) available for triazoles and Heart Disease, Ischemic
| Article | Year |
|---|---|
Chronic dipeptidyl peptidase-4 inhibition with sitagliptin is associated with sustained protection against ischemic left ventricular dysfunction in a pilot study of patients with type 2 diabetes mellitus and coronary artery disease.
Topics: Aged; Coronary Angiography; Coronary Artery Disease; Diabetes Mellitus, Type 2; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidase IV Inhibitors; Echocardiography, Doppler; Echocardiography, Stress; Electrocardiography; Female; Follow-Up Studies; Glucagon-Like Peptide 1; Heart Ventricles; Humans; Male; Myocardial Ischemia; Pilot Projects; Pyrazines; Sitagliptin Phosphate; Stroke Volume; Treatment Outcome; Triazoles; Ventricular Dysfunction, Left | 2014 |
21 other study(ies) available for triazoles and Heart Disease, Ischemic
| Article | Year |
|---|---|
NOX4-dependent neuronal autotoxicity and BBB breakdown explain the superior sensitivity of the brain to ischemic damage.
Topics: Animals; Benzoxazoles; Blood-Brain Barrier; Brain; Brain Ischemia; Endothelial Cells; Enzyme Inhibitors; Female; Femoral Artery; Gene Expression Regulation; Hindlimb; Humans; Male; Mice; Mice, Knockout; Myocardial Ischemia; NADPH Oxidase 4; Neurons; Neuroprotective Agents; Organ Specificity; Pyrazoles; Pyridones; Rats; Signal Transduction; Triazoles | 2017 |
Comparative safety and effectiveness of sitagliptin in patients with type 2 diabetes: retrospective population based cohort study.
Topics: Comparative Effectiveness Research; Confounding Factors, Epidemiologic; Diabetes Complications; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Drug Therapy, Combination; Female; Hospitalization; Humans; Hypoglycemic Agents; Insurance, Health; Male; Middle Aged; Myocardial Ischemia; Practice Guidelines as Topic; Propensity Score; Proportional Hazards Models; Pyrazines; Retrospective Studies; Sitagliptin Phosphate; Time Factors; Treatment Outcome; Triazoles; United States | 2013 |
First treatment of a child suffering from severe ischemic cardiomyopathy with G-CSF and sitagliptin.
Topics: Cardiomyopathies; Combined Modality Therapy; Dipeptidyl-Peptidase IV Inhibitors; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Humans; Infant; Male; Myocardial Ischemia; Pyrazines; Severity of Illness Index; Sitagliptin Phosphate; Treatment Outcome; Triazoles | 2013 |
Cooperative role of endogenous leucotrienes and platelet-activating factor in ischaemia-reperfusion-mediated tissue injury.
Topics: Amidines; Animals; Azepines; Biological Assay; Carbamates; Dermis; Disease Models, Animal; Extravasation of Diagnostic and Therapeutic Materials; Extremities; Inflammation; Leukotriene B4; Leukotrienes; Male; Mice; Mice, Inbred C57BL; Myocardial Ischemia; Neutrophil Infiltration; Platelet Activating Factor; Platelet Membrane Glycoproteins; Propionates; Quinolines; Rabbits; Receptors, G-Protein-Coupled; Receptors, Leukotriene; Reperfusion Injury; Triazoles | 2013 |
Diaporthe soft tissue infection in a heart transplant patient.
Topics: Aged; Antifungal Agents; Ascomycota; DNA, Fungal; Glycopeptides; Heart Transplantation; Humans; Immunosuppression Therapy; Male; Mycoses; Myocardial Ischemia; Polymerase Chain Reaction; Soft Tissue Infections; Thigh; Tomography, X-Ray Computed; Triazoles | 2017 |
Cardioprotection induced by adenosine A1 receptor agonists in a cardiac cell ischemia model involves cooperative activation of adenosine A2A and A2B receptors by endogenous adenosine.
Topics: Acetamides; Adenosine; Adenosine A1 Receptor Agonists; Adenosine A2 Receptor Agonists; Adenosine A2 Receptor Antagonists; Adenosine A3 Receptor Agonists; Adenosine A3 Receptor Antagonists; Aminopyridines; Animals; Apoptosis; Cardiotonic Agents; Cell Line; Cell Survival; Dihydropyridines; Imidazoles; Myocardial Ischemia; Phenethylamines; Purines; Rats; Triazines; Triazoles; Xanthines | 2009 |
Genetic deletion or pharmacological inhibition of dipeptidyl peptidase-4 improves cardiovascular outcomes after myocardial infarction in mice.
Topics: Animals; Cardiovascular System; Coronary Vessels; Diabetes Mellitus, Experimental; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidase IV Inhibitors; Gene Deletion; Heart; Hypoglycemic Agents; Male; Metformin; Mice; Mice, Inbred C57BL; Mice, Knockout; Myocardial Infarction; Myocardial Ischemia; Pyrazines; Reference Values; Reperfusion; Sitagliptin Phosphate; Survivors; Triazoles | 2010 |
Contribution of adenosine A(2A) and A(2B) receptors to ischemic coronary dilation: role of K(V) and K(ATP) channels.
Topics: 4-Aminopyridine; Adenosine; Adenosine A2 Receptor Agonists; Adenosine A2 Receptor Antagonists; Animals; Coronary Circulation; Disease Models, Animal; Dogs; Flavins; Glyburide; Hyperemia; KATP Channels; Male; Myocardial Ischemia; Phenethylamines; Potassium Channel Blockers; Potassium Channels, Voltage-Gated; Pyrimidines; Receptor, Adenosine A2A; Receptor, Adenosine A2B; Triazoles; Vasodilation | 2010 |
A novel, potent, and selective inhibitor of cardiac late sodium current suppresses experimental arrhythmias.
Topics: Acetanilides; Action Potentials; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cardiotonic Agents; Cnidarian Venoms; Female; Flecainide; Heart Conduction System; Long QT Syndrome; Mutation; Myocardial Ischemia; Myocytes, Cardiac; Patch-Clamp Techniques; Piperazines; Potassium Channel Blockers; Pyridines; Quaternary Ammonium Compounds; Rabbits; Ranolazine; Sodium Channel Blockers; Triazoles | 2013 |
Left regional cardiac perfusion in vitro with platelet-activating factor, norepinephrine and K+ reveals that ischaemic arrhythmias are caused by independent effects of endogenous "mediators" facilitated by interactions, and moderated by paradoxical antago
Topics: Animals; Azepines; Coronary Vessels; Heart Ventricles; In Vitro Techniques; Male; Myocardial Ischemia; Norepinephrine; Perfusion; Platelet Activating Factor; Potassium; Rats; Rats, Wistar; Triazoles; Ventricular Fibrillation; Ventricular Function | 2004 |
Superiority of voriconazole over amphotericin B in the treatment of invasive aspergillosis after heart transplantation.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Heart Transplantation; Humans; Lung Diseases, Fungal; Middle Aged; Myocardial Ischemia; Postoperative Complications; Pyrimidines; Tomography, X-Ray Computed; Triazoles; Voriconazole | 2005 |
The A2a/A2b receptor antagonist ZM-241385 blocks the cardioprotective effect of adenosine agonist pretreatment in in vivo rat myocardium.
Topics: Adenosine A2 Receptor Antagonists; Animals; Cardiotonic Agents; Drug Combinations; Male; Myocardial Ischemia; Premedication; Purinergic P1 Receptor Agonists; Rats; Rats, Sprague-Dawley; Treatment Outcome; Triazines; Triazoles | 2007 |
Adenosine and PAF dependent mechanisms lead to myocardial reperfusion injury by neutrophils after brief ischaemia.
Topics: Adenosine; Animals; Azepines; Guinea Pigs; Heart; Male; Myocardial Ischemia; Myocardial Reperfusion Injury; Neutrophil Activation; Neutrophils; Perfusion; Platelet Activating Factor; Receptors, Purinergic P1; Theobromine; Triazoles; Xanthines | 1995 |
Role of platelet-activating factor in polymorphonuclear neutrophil recruitment in reperfused ischemic rabbit heart.
Topics: Animals; Azepines; Cell Movement; Female; Heart; Hemodynamics; Male; Myocardial Infarction; Myocardial Ischemia; Myocardial Reperfusion Injury; Myocardium; Neutrophils; Platelet Activating Factor; Quinolines; Rabbits; Risk Factors; Triazoles | 1993 |
Plasma mediated neutrophil stimulation during coronary angioplasty: autocrine effect of platelet activating factor.
Topics: Angioplasty, Balloon, Coronary; Azepines; CD18 Antigens; Cells, Cultured; Coronary Circulation; Diterpenes; Femoral Artery; Femoral Vein; Ginkgolides; Humans; Lactones; Myocardial Ischemia; Neutrophil Activation; Neutrophils; Platelet Activating Factor; Superoxides; Triazoles | 1995 |
Effect of a new nitric oxide donor on the biomechanical performance of the isolated ischaemic rat heart.
Topics: Animals; Biomechanical Phenomena; Bradykinin; Heart; In Vitro Techniques; Male; Myocardial Ischemia; Nitric Oxide; Platelet Aggregation Inhibitors; Rats; Rats, Wistar; Reperfusion Injury; Triazoles; Vascular Resistance; Vasodilator Agents; Ventricular Function, Left | 1997 |
Brief myocardial ischemia attenuates platelet thrombosis in remote, damaged, and stenotic carotid arteries.
Topics: Adenosine; Animals; Blood Platelets; Carotid Artery Thrombosis; Carotid Stenosis; Dogs; Myocardial Ischemia; Quinazolines; Rabbits; Receptors, Purinergic P1; Triazoles; Vascular Patency | 1999 |
Protection against ventricular fibrillation by the PAF antagonist, BN-50739, involves an ischaemia-selective mechanism.
Topics: Animals; Anti-Arrhythmia Agents; Azepines; Disease Models, Animal; Male; Myocardial Ischemia; Perfusion; Platelet Activating Factor; Protective Agents; Rats; Rats, Wistar; Triazoles; Vasodilation; Ventricular Fibrillation | 1999 |
Modulation of antigen- and ischemia-induced effects by the platelet-activating factor antagonist WEB-2086 in isolated sensitized rat hearts.
Topics: Anaphylaxis; Animals; Antigens; Azepines; Chromatography, High Pressure Liquid; Chromones; Coronary Circulation; Heart; Histamine Release; In Vitro Techniques; Male; Myocardial Ischemia; Myocardial Reperfusion; Platelet Activating Factor; Pressure; Rats; Rats, Wistar; Triazoles | 1992 |
Inhibition of platelet-activating factor fails to limit ischemia and reperfusion-induced myocardial damage.
Topics: Animals; Azepines; Blood Pressure; Coronary Circulation; Dogs; Heart Rate; Male; Myocardial Infarction; Myocardial Ischemia; Myocardial Reperfusion Injury; Platelet Activating Factor; Platelet Aggregation; Triazoles | 1992 |
Effects of the PAF antagonists BN50726 and BN50739 on arrhythmogenesis and extent of necrosis during myocardial ischaemia/reperfusion in rabbits.
Topics: Animals; Arrhythmias, Cardiac; Azepines; Blood Pressure; Electrocardiography; Heart Rate; Hemodynamics; Myocardial Infarction; Myocardial Ischemia; Myocardial Reperfusion Injury; Necrosis; Platelet Activating Factor; Rabbits; Thienopyridines; Triazoles | 1992 |